TOKYO (Reuters) – Japan is likely to approve COVID-19 vaccines by both AstraZeneca and Moderna Inc, with an official announcement expected from the country’s health minister on Friday, public broadcaster NHK reported on Thursday.
Officials are considering limiting the recommended age group for AstraZeneca’s vaccine due to worries about blood clots, the report said.
Novo Nordisk contracts Aspen to produce insulin for Africa | Reuters Novo Nordisk (NOVOb.CO) has contracted...
Germany on Monday launched its autumn vaccination campaign to prevent respiratory infection, promoting an updated COVID-19...
Wendy Nelson stands at Uhuru Peak of Mt. Kilimanjaro, the highest point on the continent of...
Wendy Nelson watched her mother slowly die of Alzheimer’s disease, unable to move or swallow at...
Why Europe’s drug shortages may get worse | Reuter Most European countries reporting shortages of antibiotics...
